Whalesbook
Shaily Engineering Plastics Reports Strong FY26 Results, Eyes Expansion
Shaily Engineering Plastics announced its financial results for the fiscal year ending March 31, 2026. The company reported a significant increase in its consolidated revenue, which grew by 26% year-on-year to ₹990.7 crore. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) saw a substantial jump of 61% to ₹287.7 crore. Net profit, or Profit After Tax (PAT), surged by 83% to ₹169.9 crore.
In the fourth quarter of FY26, revenue rose 9% to ₹236.8 crore, EBITDA increased by 27% to ₹69.3 crore, and PAT grew by 40% to ₹40.2 crore.
Why This Matters
These strong financial results signal healthy operational performance and effective management. The significant profit growth points to improved efficiency and successful expansion, particularly within the high-demand healthcare segment. The company also secured a substantial ₹423 crore order for pen injectors, providing a visible revenue stream for the next four years. Additionally, the board approved an enabling resolution to raise up to ₹500 crore, indicating potential strategic investments or expansion plans.
Business Diversification and Future Growth
Shaily Engineering Plastics has been actively diversifying its business into new, high-growth areas such as consumer electronics and semiconductor trays. The company is strengthening its manufacturing capabilities and expanding its product portfolio to meet evolving market demands. The approved fund-raising resolution offers financial flexibility to pursue growth opportunities and develop into a global, intellectual property-led manufacturing platform. The ₹423 crore pen injector order will directly contribute to revenue over the next four years.
Key Risks
The company's performance is exposed to general economic conditions both domestically and internationally. Key risks include industry competition, the pace of strategic implementation, technological shifts, and effective management of revenue and cash flows.
Performance Metrics
- FY26 Consolidated Revenue: ₹990.7 crore (+26% YoY)
- FY26 Consolidated EBITDA: ₹287.7 crore (+61% YoY)
- FY26 Consolidated PAT: ₹169.9 crore (+83% YoY)
- Q4 FY26 Consolidated Revenue: ₹236.8 crore (+9% YoY)
- Q4 FY26 Consolidated EBITDA: ₹69.3 crore (+27% YoY)
- Q4 FY26 Consolidated PAT: ₹40.2 crore (+40% YoY)
- Pen injector order value: ₹423 crore
- Potential fundraising: Up to ₹500 crore
What to Watch Next
Investors should monitor the progress of the ₹500 crore fund-raising initiative and its intended use. Tracking the performance and order book for new business segments like consumer electronics and semiconductor trays will also be crucial.